The UK government’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued consumer guidance on recognising and reporting suspected adverse effects from e-cigarette use, as use of vaping products continues to rise across Europe and globally. The guidance aims to help consumers identify potential safety concerns and understand the formal reporting mechanisms available to them.
Key takeaways
- The MHRA provides a standardised framework for consumers to identify and report suspected e-cigarette side effects
- Formal reporting channels through the MHRA’s Yellow Card scheme allow adverse events to be tracked and investigated
- Side effect monitoring is essential as e-cigarette markets expand without complete long-term safety data
E-cigarette safety monitoring: The role of consumer reporting
Formal adverse event reporting systems like the MHRA Yellow Card scheme capture suspected side effects and help identify emerging safety signals
Source: MHRA consumer guidance summary | Georgian Medical Journal News
Identifying potential e-cigarette side effects
According to the MHRA guidance document, consumers should remain alert to a range of potential adverse effects from e-cigarette use. These include respiratory symptoms such as cough, shortness of breath, and chest discomfort, as well as oral and throat irritation, mouth ulcers, and gum problems.
The MHRA also notes that some users have reported cardiovascular symptoms, including palpitations and chest pain, though causality investigations remain ongoing. Allergic reactions and dermatological symptoms have similarly been documented in consumer reports. This guidance reinforces that while e-cigarettes are often marketed as less harmful than combustible tobacco, they are not risk-free products and warrant active safety monitoring.
How to report suspected side effects formally
The MHRA’s Yellow Card scheme provides a formal reporting mechanism for consumers and healthcare professionals to document suspected adverse effects. This system, the same mechanism used for pharmaceutical drugs and medical devices, allows regulators to detect emerging safety signals and take rapid action if necessary.
Consumers can report suspected side effects directly through the MHRA website, by post, or through their healthcare provider. The Yellow Card scheme is essential for post-market surveillance, as it captures real-world experiences that may not have been evident during product development. Detailed, timely reporting strengthens the evidence base and helps protect other users from potential harms. See our Quality & Safety coverage for more on adverse event monitoring systems.
Why consumer reporting matters for regulatory oversight
E-cigarette products have proliferated faster than regulatory capacity in many jurisdictions, leaving significant gaps in long-term safety data. According to the MHRA framework, systematic consumer reporting is one of the most effective tools for identifying patterns of harm that may only emerge months or years after product launch.
Because e-cigarette users are often former smokers managing nicotine dependence, they may tolerate or minimise side effects that would otherwise prompt medical attention. Consumer education campaigns and clear reporting pathways help ensure that health signals are not lost. This approach aligns with Health Policy frameworks for adaptive regulation of consumer products. The MHRA’s transparent guidance strengthens public trust in regulatory systems and encourages proactive health-seeking behaviour.
Consumer reporting through formal adverse event systems is essential for identifying emerging safety signals from e-cigarettes, given the limited long-term data available on these rapidly evolving products.
— MHRA Consumer Guidance Framework (UK Medicines and Healthcare products Regulatory Agency)
What this means
Frequently asked questions
What are the most commonly reported side effects from e-cigarettes?
According to the MHRA guidance, the most frequently reported adverse effects include cough, throat irritation, mouth ulcers, palpitations, and shortness of breath. These symptoms may develop acutely or gradually with chronic use.
How do I report a suspected side effect from an e-cigarette?
You can report suspected side effects through the MHRA Yellow Card online portal, by post, or by asking your healthcare provider to submit a report on your behalf. All reports are reviewed by MHRA pharmacovigilance specialists.
Are e-cigarettes safe if I do not experience side effects?
The absence of acute side effects does not indicate long-term safety. Long-term effects of e-cigarette use remain under investigation. The MHRA guidance emphasises that users should understand that e-cigarettes are not risk-free and that nicotine itself carries cardiovascular risks regardless of delivery method.
As e-cigarette markets continue to expand globally, the MHRA’s consumer guidance represents a critical step in building robust post-market surveillance systems. Effective pharmacovigilance depends on transparent communication between users, healthcare providers, and regulators—and on the willingness of consumers to report adverse events they experience. Strengthening these feedback loops helps ensure that regulatory decisions remain grounded in real-world evidence rather than marketing claims. Public health authorities in other countries should consider adopting similar frameworks to protect populations using these emerging nicotine delivery devices.
Source: Advice for consumers: E-cigarettes and suspected side effects — UK Medicines and Healthcare products Regulatory Agency (MHRA)
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
